Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cooper

Showing results (241-250 of 319) with videos related to

Pageof 32
Sort By:
Biorxiv : the Preprint Server for Biology|March 30, 2023
Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing <i>in vivo</i>Han Zhang, Karen Kelly, Jonathan Lee, et al.
BMJ Open|December 12, 2018
Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocolJane E Norman, John Norrie, Graeme Maclennan, et al.
Infectious Diseases and Therapy|September 12, 2023
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in AdultsLouise Murdoch, Karen Quan, James A Baber, et al.
Trials|March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trialDiana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
Vaccines|April 27, 2026
A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results)Rucha Dadhe, Juleen Gayed, Muneeb Iqbal, et al.
Nucleic Acids Research|November 30, 2023
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivoHan Zhang, Karen Kelly, Jonathan Lee, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
Vaccines|February 26, 2025
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of AgeJoel M Neutel, Rahsan Erdem, Qin Jiang, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
Pageof 32

Showing results (241-250 of 319) with videos related to

Sort By:
Pageof 32
Biorxiv : the Preprint Server for Biology|March 30, 2023
Self-delivering CRISPR RNAs for AAV Co-delivery and Genome Editing <i>in vivo</i>Han Zhang, Karen Kelly, Jonathan Lee, et al.
BMJ Open|December 12, 2018
Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocolJane E Norman, John Norrie, Graeme Maclennan, et al.
Infectious Diseases and Therapy|September 12, 2023
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in AdultsLouise Murdoch, Karen Quan, James A Baber, et al.
Trials|March 21, 2026
PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trialDiana Johnson, Ruth Thomas, Seonaidh Cotton, et al.
Vaccines|April 27, 2026
A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18-64 Years of Age (Preliminary Results)Rucha Dadhe, Juleen Gayed, Muneeb Iqbal, et al.
Nucleic Acids Research|November 30, 2023
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivoHan Zhang, Karen Kelly, Jonathan Lee, et al.
The New England Journal of Medicine|January 18, 2013
Short-course antiretroviral therapy in primary HIV infection, Sarah Fidler, Kholoud Porter, et al.
Vaccines|February 26, 2025
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of AgeJoel M Neutel, Rahsan Erdem, Qin Jiang, et al.
Elife|September 14, 2014
HIV-1 DNA predicts disease progression and post-treatment virological controlJames P Williams, Jacob Hurst, Wolfgang Stöhr, et al.
AIDS (London, England)|April 2, 2005
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosineAna Barrios, Ana Rendón, Eugenia Negredo, et al.
Pageof 32